Lianhua Qingwen for the Rehabilitation of Patient With Coronavirus Infection
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The patients with coronavirus infection usually have fever, respiratory symptoms, headache,
toothache, muscle soreness, physical decline, and so on, while others are asymptomatic
patients. It is urgent to find drugs to improve the long-term rehabilitation of symptomatic
patients with coronavirus infection and decrease the duration of viral shedding in both
symptomatic and asymptomatic patients. This study aims to investigate the efficacy and safety
of Lianhua Qingwen capsules in patients with coronavirus infection. The duration of viral
shedding and symptoms before discharge, as well as the negative conversion ratio and
disappearance ratio of main symptoms after 7-day treatment, will be evaluated. 6-month
follow-up will be performed to evaluate the effect of Lianhua Qingwen on all infection events
and the long-term rehabilitation of the symptoms induced by coronavirus infection.